Researchers are combining multiplexed assays to improve the classification of variants of the BRCA2 gene. This approach may also be applied to BRCA1 variants, with some studies suggesting it can provide strong evidence for classifying hundreds of variants of uncertain significance. The method involves functional evaluation and integration of functional assay data to enhance variant classification.